Across skin, wounds, soil, and plant roots, microorganisms play a critical role in shaping biological conditions. At AMS BioteQ, we view microbes not simply as threats, but as biological factors that can be precisely understood and regulated.
Originating from research in dengue, Zika, and avian influenza, the Company has established a pharmaceutical-grade ingredient database and molecular structure design capabilities. Through continued R&D, we identified a key principle underlying health and regeneration: the importance of microbiome balance.
Leveraging a pharmaceutical approach across skincare and medical applications, AMS BioteQ develops ingredients designed to deliver both safety and efficacy. Preliminary studies have demonstrated significant wound-healing potential, with particularly notable results in diabetic wound models.















